Interventions for chronic palmoplantar pustulosis

Cochrane Database of Systematic Reviews

Volumn 2006, Issue 1, 2006, Pages

  Chalmers, Robert ^a   Hollis, Sally ^b   Leonardi Bee, Jo ^b   Griffiths, Christopher Em ^a   Marsland, Alexander ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Dermatology Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CYCLOSPORINE; METHOXSALEN; RETINOID; STEROID; TETRACYCLINE;

CHRONIC DISEASE; DISEASE CLEARANCE; DISEASE SEVERITY; GRENZ RAY THERAPY; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; PUVA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 33947397992     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001433.pub2     Document Type: Review

References (57)

1. Bhushan M, Burden AD, McElhone K, James R, Vanhoutte FP, Griffiths CEM. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study. British Journal of Dermatology 2001;145:546-53.
2. Erkko P, Granlund H, Remitz A, Rosen K, Mobacken H, Lindeloef B, et al. Double-blind placebo-controlled trial of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis. British Journal of Dermatology 1998;139(6):997-1004.
3. Foged E, Holm P, Larsen P, Laurberg G, Reymann F, Roesdahle K, et al. A randomized trial of etretinate (Tigason) in palmoplantar pustulosis. Dermatologica 1983;166:220-3.
4. Hattel T, Sondergaard J. Pustulosis palmaris et plantaris treated with Hydroxyurea. Acta Dermatovenereologica 1974;54:152-4.
5. Jansen C, Hollmen, Pajarre R. Peroral aromatic retinoid treatment of palmoplantar pustulosis: double-blind comparison of Ro 10-9359 and placebo. Acta Dermatovenereologica 1978;59:271-3.
6. Kragballe K, Larsen F G. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Dermatovenereologica 1991;71:540-2.
7. Lassus A, Lauharanta J, Juvakoski T, Kanerva L. Efficacy of etretinate (tigason) in clearing and prevention of relapse of palmoplantar pustulosis. Dermatologica 1983;166:215-9.
8. Lassus A, Lauharanta J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. British Journal of Dermatology 1985;112:455-9.
9. Lassus A, Geiger JM. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. British Journal of Dermatology 1988;119:755-9.
10. Lawrence CM, Marks J, Parker S, Shuster S. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. British Journal of Dermatology 1984;110:221-6.
11. Layton AM, Sheehan-Dare R, Cunliffe WJ. A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. British Journal of Dermatology 1991;124:581-4.
12. Lindeloef B, Beitner H. The effect of grenz ray therapy on pustulosis palmoplantaris. Acta Dermato-Venereologica 1990;70:529-31.
13. Mann RJ. Failure of colchicine for palmo-plantar pustulosis. British Journal of Dermatology 1982;106:373.
14. Matsunami E, Takashima A, Mizuno N, Jinno T, Ito H. Topical PUVA, etretinate, and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections. Journal of Dermatology 1990;17(2):92-6.
15. Murray D, Corbett MF, Warin AP. A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. British Journal of Dermatology 1980;102:659-3.
16. Nielsen PG, Madsen SM. Occlusive treatment of palmoplantar pustular psoriasis with clobetasol propionate ointment succeeded by short-term PUVA. Journal of Dermatological Treatment 1995;6:77-9.
17. Reitamo S, Erkko P, Remitz A, Lauerma AI, Montonen O, Harjula K. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Archives of Dermatology 1993;129:1273-9.
18. Rosen K, Mobacken H, Swanbeck G. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. Archives of Dermatology 1987;123:885-9.
19. Thestrup-Pedersen K, Reymann F. Treatment of Pustulosis palmaris et plantaris with Colchicine. Acta Derm Venereol 1984;64:76-8.
20. Thomsen K, Osterbye P. Pustulosis palmaris et plantaris. British Journal of Dermatology 1973;89:293-6.
21. Ward JM, Corbett MF, Hanna MJ. A double-blind trial of clomocycline in the treatment of persistent pustulosis. British Journal of Dermatology 1976;95:317-22.
22. White SI, Marks JM, Shuster S. Etretinate in pustular psoriasis of palms and soles. British Journal of Dermatology 1985;113(5):581-5.
23. White SI, Puttick L, Marks JM. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. British Journal of Dermatology 1986;115:577-82.
24. Abel EA, Goldberg LH, Farber EM. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light. Archives of Dermatology 1980;116:1257-61.
25. Agren-Jonsson S, Tegner E. PUVA Therapy for Palmoplantar Pustulosis. Acta Derm Venereol 1985;65:531-5.
26. Allenby CF. Relapsing pustular eruption of hands and feet treated with local methotrexate. British Journal of Dermatology 1966;78:154-7.
27. Coleman WR, Lowe NJ, David M, Halder RM. Palmoplantar psoriasis: Experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device. Journal of the American Academy of Dermatology 1989;20:1078-81.
28. Davis MD, McEvoy MT, El-Azhary RA. Topical Psoralen-Ultraviolet A Therapy for Palmoplantar Dermatoses: Experience With 35 Consecutive Patients. Mayo Clinical Proceedings. 1998;73:407-11.
29. De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. British Journal of Dermatology 1995;132:964-9.
30. Duweb GA, Abuzariba O, Rahim M, al-Taweel M, al-Alem S, Abdulla SA. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis. International Journal of Tissue Reactions 2001;23(2):59-62.
31. Fredriksson T, Pettersson U. Oral treatment of pustulosis palmo-plantaris with a new retinoid, R0 10-9359. Dermatologica 1979;158:60-4.
32. Goette DK, Morgan AM, Fox BJ, Horn RT. Treatment of palmoplantar pustulosis with intralesional triamcinolone injections. Archives of Dermatology 1984;120:319-23.
33. Jansen CT, Malmiharju T. Inefficacy of topical methoxalen plus UVA for palmoplantar pustulosis. Acta Dermatovenereologica 1981;61:354-6.
34. Kumar B, Kumar R, Kaur I. Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle?. International Journal of Dermatology 1997;36(4):309-12.
35. Meinardi MM, De Rie MA, Bos JD. Oral Cyclosporin A Is Effective in Clearing Persistent Pustulosis Palmaris et Plantaris. Acta Dermatovenereologica 1990;70:77-9.
36. Morison WL, Parrish JA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles. British Journal of Dermatology 1978;99:297-302.
37. Schröder K, Zaun H, Holzmann H, Altmeyer P, El-Gammal S. Pustulosis palmo-plantaris. Clinical and histological changes during etretin (acitretin) therapy. Acta Dermatovenereologica 1989;146 Suppl:111-16.
38. Shephard SE, Schregenberger N, Dummer R, Panizzon RG. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinin (TM)) in local PUVA therapy. Dermatology 1998;197(1):25-30.
39. Thomsen K. Pustulosis palmaris et plantaris treated with methotrexate. Acta Dermatovenereol 1971;51:397-400.
40. Thune P. Treatment of palmoplantar pustulosis with Tigason. Dermatologica 1982;164:67-72.
41. Vahlquist C, Michaelsson G, Vahlquist A, Vessby B. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins. British Journal of Dermatology 1985;112(1):69-76.
42. Volden G. Successful Treatment of Chronic Skin Diseases with Clobetasol Propionate and a Hydrocolloid Occlusive Dressing. Acta Derm Venereol 1992;72:69-71.
43. Wilkinson JD, Ralfs IG, Harper JI, Black MM. Topical methoxsalen photochemotherapy in the treatment of palmoplantar pustulosis and psoriasis. Acta Dermato-Venereologica 1979;Vol 59 Supplementum 85:193-8.
44. Asumalahti K, Ahmeen M, Evans T, Burden D, Griffiths CEM, Barker JNWN, et al. Analysis of PSORS1 single nucleotide polymorphisms in guttate psoriasis and palmoplantar pustular psoriasis. British Journal of Dermatology 2002;147:1053.
45. Camp RDR. Psoriasis. In: Champion RH, Burton JL, Burns DA, Breathnach SM editor(s). Textbook of Dermatology. 6th Edition. Oxford: Blackwell Scientific, 1998:1589-649.
46. Edlund E, Johnsson U, Lidgren L, Pettersson H, Sturfelt G, Svensson B, et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Annals of the Rheumatic Diseases 1988;47:809-15.
47. Enfors W, Molin L. Pustulosis palmaris et plantaris: a follow-up study of a ten-year material. Acta Dermatovenereol 1971;51:289-94.
48. Eriksson MO, Hagforsen E, Lundin IP, Michaelsson G. Palmoplantar pustulosis: a clinical and immunohistological study. British Journal of Dermatology 1998;138(3):390-8.
49. Hagforsen E, Awder M, Lefvert AK, Nordlind K, Michaelsson G. Palmoplantar pustulosis: an autoimmune disease precipitated by smoking?. Acta Dermato-Venereologica 2002;82:341-6.
50. Jurik AG, Ternowitz T. Frequency of skeletal disease: arthro-osteitis in patients with pustulosis palmoplantaris. Journal of the Ameican Academy of Dermatology 1988;18:666-71.
51. Kubeyinje EP, Belagavi CS. Risk factors for palmo-plantar pustulosis in a developing country. East African Medical Journal 1997;74(1):54-5.
52. Le Loet X, Bonnet B, Thomine E, Mejjad O, Lucet L, Louvel JP, et al. Osteoarticular manifestations of palmoplantaris pustulosis. A prospective study of 15 cases. Presse Medicale. 20(28):1307-11, 1991 1991;20(28):1307-11.
53. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Statistics in Medicine 1998;17:2635-50.
54. Nymann P, Kollerup G, Jemec GB, Grossmann E. Decreased bone mineral density in patients with pustulosis et plantaris. Dermatology 1996;192(4):307-11.
55. ODoherty CJ, Macintyre C. Palmoplantar pustulosis and smoking. British Medical Journal 1985;291:861-4.
56. Rosen K, Lindstedt G, Mobacken H, Nystrom E. Thyroid function in patients with pustulosis palmoplantaris. Journal of the American Academy of Dermatology 1988;19(6):1009-16.
57. Saez-Rodriguez M, Noda-Cabrera A, Alvarez-Tejera S, Guimera-Martin-Neda F, Dorta-Alom S, Escoda-Garcia M, Fagundo-Gonzalez E, Sanchez-Gonzalez R, Garcia-Montelongo R, Garcia-Bustinduy M. The role of psychological factors in palmoplantar pustulosis. Journal of the European Academy of Dermatology & Venereology 2002;16:325-327.